D. E. Shaw & Co., Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,140,271
-61.1%
44,629
-56.3%
0.00%
-66.7%
Q2 2023$2,927,855
-38.4%
102,087
-20.5%
0.00%
-25.0%
Q4 2021$4,750,000
+3.8%
128,363
+34.0%
0.00%0.0%
Q3 2021$4,575,000
-55.7%
95,766
-68.6%
0.00%
-55.6%
Q2 2021$10,324,000
+212.7%
305,090
+281.7%
0.01%
+200.0%
Q1 2021$3,302,000
+1100.7%
79,938
+1260.9%
0.00%
Q2 2020$275,0005,8740.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 8,394$264,6630.19%
Global Wealth Strategies & Associates 100$3,1530.00%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders